Course Description
Please join us for a 3-part, CME, virtual webinar series featuring expert discussion of Aplastic Anemia, hosted by Carilion Clinic.
SPEAKER:
Dr. William Fintel, MD
Medical Director, Carilion Clinic
MODERATOR:
Dr. Apostolos Dallas, MD
Associate Professor, Internal Medicine, Virginia Tech Carilion School of Medicine
CME Director, Carilion Clinic
May 4, 2023 |
8:30 AM EST
Virtual Carilion Clinic Spring Symposium
Pancytopenia: An Old-Fashioned Approach
SPEAKER:
Dr. Brant Ward, MD, PhD
Assistant Professor of Medicine, Virgina Commonwealth University
MODERATOR:
Dr. Darian Wang, MD
Residency Associate Program Director, Virginia Tech Carilion School of Medicine
May 12, 2023 |
7:30 AM EST
Medical Grand Rounds
Immunopathogenesis of Aplastic Anemia
SPEAKER:
Dr. Elizabeth Krieger, MD
Hematology and Oncology, Virgina Commonwealth University
MODERATOR:
Dr. Darian Wang, MD
Residency Associate Program Director, Virginia Tech Carilion School of Medicine
May 19, 2023 |
7:30 AM EST
Medical Grand Rounds
Evolving Immunotherapies and Allogenic Hematopoietic Stem Cell Transplants (HSCT)
Overall Learning Objectives
Following the educational activities, participants will be able to:
- Improve the care of patients through early identification and diagnosis of Aplastic Anemia.
- Have increased awareness of Aplastic Anemia to refer patients to higher clinical centers of reference
- Understand and implement current standards for the treatment for Aplastic Anemia and its complications.
- Standardize the clinical management of special patient subpopulations and difficult cases of Aplastic Anemia patients.
Learning Objectives — May 4th Session
- Recognize three general categories of pancytopenia: Normocellular marrow, Hypercellular marrow, Hypocellular marrow.
- Recognize the Myriad of treatment options, all dependent on a correct diagnosis, to help steer and treat your patient.
Learning Objectives — May 12th Session
- Describe the primary and secondary causes of bone marrow aplasia.
- Identify inherited causes of bone marrow failure.
- Apply features of inherited immune disorders to the pathogenesis of bone marrow aplasia.
Learning Objectives — May 19th Session
- Analyze the genetic predispositions that can lead to bone marrow aplasia
- Evaluate the genetic causes of bone marrow aplasia that necessitate modified treatment approaches
- Comprehend the dynamic landscape of immunosuppressive therapy for the management of aplastic anemia
- Examine the role of transplantation as a potential curative treatment option for aplastic anemia
- Discuss current and emerging clinical trials exploring novel treatment strategies for aplastic anemia.
Target Audience
Internal Medicine providers, Hematologists, Medical Oncologists, Pathologists, Primary Care Physicians, Nurses, Mid-Level Providers, Residents, Fellows, and any other members of the hematology care team.
Identification and Mitigation of Disclosure of Financial Relationships
Planning Committee: Dr. Paul Dallas, Dr. William Fintel, Hien Thach, RN, and Linda Wells, CHCP reported no relevant relationships/affiliations with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.